Craif Raises $33M to Accelerate Introduction of Its Urine-Based Cancer Test to the U.S.Series D, Co-led by Granite-Integral and Diagnostics Maker Tauns, Funds a Prospective Pancreatic Cancer Study and Expansion of U.S. Clinical Team Under New Chief Medical Officer Nick Bevins
